Search

Filters

Clear Filters
4:20 PM - 4:25 PM PT

1063 - Dose-Volume Predictors for Radiation Esophagitis in Breast Cancer Patients Undergoing Conventional Fractionated Regional Nodal Radiotherapy: A Prospective Study
Speaker: Wang, Dan-Qiong, MD - National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade, ???, Beijing
4:25 PM - 4:30 PM PT

1064 - Dosimetric Correlates of Acute Toxicities for Hypofractionated Whole-Breast Irradiation, A Single Institution Retrospective Investigation: Is There a Need to Update the Guidelines?
Speaker: Dumane, Vishruta, PhD - Icahn School of Medicine at Mount Sinai, New York, NY
4:30 PM - 4:35 PM PT

1065 - Patient Reported Outcomes following Accelerated Partial Breast vs. Ultrahypofractionated/Hypofractionated Whole Breast: A Single Institution Comparison Study
Speaker: Rau, Allison, MD, MS - Arthur JE Child Comprehensive Cancer Centre, Calgary, AB
4:05 PM - 4:10 PM PT

1066 - Multi-Omics Analyses of Biological Difference between Photon and Proton Irradiation on Glioblastoma Organoids
Speaker: Zhao, Jianyi, RT - Department of Radiation Oncology, Ruijin Hospital, Shang- hai Jiao Tong University School of Medicine, shanghai, shanghai
4:10 PM - 4:15 PM PT

1067 - Toxicity and Clinical Outcomes of Proton vs. Photon Volumetric Modulated Arc Therapy Craniospinal Irradiation for Solid Tumor Leptomeningeal Carcinomatosis
Speaker: Lamanilao, Gene, MD, MS, BS - University of California San Diego, La Jolla, CA
4:30 PM - 4:35 PM PT

1068 - Results of a Randomized Phase 2 Study of a Novel Superoxide Dismutase Mimetic in Patients with Multiple Brain Metastases undergoing Whole-Brain Radiotherapy
Speaker: Kirkpatrick, John, MD, PhD, FASTRO - Duke University Medical Center, Durham, North Carolina
4:15 PM - 4:20 PM PT

1069 - Characterization of Glioblastoma Infiltration and Survival by Brain Regions
Speaker: Yeo, Wan-Jin, PhD - University of California, San Francisco, San Francisco, CA
2:30 PM - 2:40 PM PT

107 - Quality of Life and 5-Year Long-Term Organ Preservation in Early Rectal Adenocarcinoma Final Results from the OPERA Trial
Speaker: Barbet, Nicolas, MD - ORLAM, villeurbanne, RHONE ALPES
4:20 PM - 4:25 PM PT

1070 - Induction-Concurrent Chemoradiotherapy with or without Camrelizumab for Postoperative Residual High-Grade Gliomas: An Open, Randomized, Phase II Clinical Study
Speaker: Luo, Xiuling, BS - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
4:25 PM - 4:30 PM PT

1071 - A Prospective Study to Evaluate the Impact of Radiotherapy Technique - 3DCRT vs. Hippocampal Sparing Volumetric Modulated Arc Therapy (hsVMAT) - on Neurocognitive Function (NCF) in Adults with Grade 2-3 Gliomas
Speaker: Goyal, Shikha, MD, MBBS - Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh
4:05 PM - 4:10 PM PT

1072 - Interim Analysis of a Phase 2 Single Arm Trial of Extended Lymph Node Proton Irradiation for High Risk Prostate Cancer
Speaker: Patel, Pretesh, MD - Emory University School of Medicine, Atlanta, GA
4:10 PM - 4:15 PM PT

1073 - Second-Line Radiation Therapy for Locally Recurrent Prostate Cancer after Focal Therapy: A Single Institution Matched-Pair Analysis
Speaker: Kalahasti, Nikitha, BS - Stanford University, San Jose, CA